glp-1 law firm in louisiana vomiting office SIDE EFFECTS OF GLP-1s: WRTV Investigates is digging into dozens of lawsuits filed in Marion County alleging drug companies "downplayed" side effects of GLP-1 medications... injectable gastroparesis semaglutide louisiana law office

Read more about Nomio on The Feed | Insider here

Milk: Zero (0) days

Diabetes - GLP-1 agonists should be primarily considered in patients with type 2 diabetes with suboptimal glycaemic control despite maximal tolerated dose of metformin (+/- other agents) especially where weight loss is desired and/or significant stroke risk is present

2024, Zheng, Zhikai, et al

Total Medicaid drug spending rose to $6 billion in 2025 from $4.8 billion in 2022, according to data provided by the Pennsylvania Department of Human Services

Related Reading Glp Receptor 1 Agonists Glp 1 Receptor Agonists For Weight Loss Glp 1 Receptor Agonist List Glp 1 Receptor Pricing and availability current as of June 2026